SVC Occlusion in Subjects With Acute Decompensated Heart Failure
NCT ID: NCT03836079
Last Updated: 2025-09-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2019-07-31
2025-02-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD
NCT03836482
Mechanically Optimizing Cardiac Preload in Heart Failure Patients
NCT04338503
Multi-Site Feasibility Testing of the Ventricular Assist Device Anticipatory Guidance Tool
NCT06823583
Reprieve Cardiovascular System for the Treatment of Subjects With Acute Decompensated Heart Failure Mechanistic Study
NCT05015764
The Epidemiology of Ventricular Assist Device-Related Infections
NCT01471795
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DEVICE_FEASIBILITY
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ADHF Patients
Treatment with preCARDIA System
preCARDIA system
Intermittent occlusion of the SVC
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
preCARDIA system
Intermittent occlusion of the SVC
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects with inadequate diuresis
* Stage C-D systolic heart failure
Exclusion Criteria
* Severe aortic or mitral valve insufficiency
* Severe peripheral vascular disease
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abiomed Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Colorado Heart & Vascular
Lakewood, Colorado, United States
Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
Tampa General Hospital
Tampa, Florida, United States
Northwestern
Chicago, Illinois, United States
University of Chicago
Chicago, Illinois, United States
Kansas University Medical Center
Kansas City, Kansas, United States
Tufts Medical Center
Boston, Massachusetts, United States
Minneapolis Heart Institute Foundation
Minneapolis, Minnesota, United States
CentraCare Heart & Vascular Center
Saint Cloud, Minnesota, United States
OhioHealth
Columbus, Ohio, United States
Providence Health & Services
Portland, Oregon, United States
Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Baylor College of Medicine
Houston, Texas, United States
Houston Methodist
Houston, Texas, United States
Baylor, Scott & White Medical Center - Temple
Temple, Texas, United States
Inova Health System
Falls Church, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kapur NK, Kiernan MS, Gorgoshvili I, Yousefzai R, Vorovich EE, Tedford RJ, Sauer AJ, Abraham J, Resor CD, Kimmelstiel CD, Benzuly KH, Steinberg DH, Messer J, Burkhoff D, Karas RH. Intermittent Occlusion of the Superior Vena Cava to Improve Hemodynamics in Patients With Acutely Decompensated Heart Failure: The VENUS-HF Early Feasibility Study. Circ Heart Fail. 2022 Feb;15(2):e008934. doi: 10.1161/CIRCHEARTFAILURE.121.008934. Epub 2022 Jan 10.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
101773-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.